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Abstract Mutations in the SPG3A gene represent a sig-
nificant cause of autosomal dominant hereditary spastic
paraplegia with early onset and pure phenotype. We
describe an Italian family manifesting a complex pheno-
type, characterized by cerebellar involvement in the pro-
band and amyotrophic lateral sclerosis-like syndrome in
her father, in association with a new mutation in SPG3A.
Our findings further widen the notion of clinical hetero-
geneity in SPG3A mutations.
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Introduction
Hereditary spastic paraplegias (HSP) are a group of neu-
rodegenerative diseases characterized by progressive
spasticity in the lower limbs, presenting either in isolation
(‘‘pure’’) or associated with a wide array of additional
features (‘‘complicated’’ forms), and great genetic hetero-
geneity sustained by the identification of 39 loci, 19 of
which are described in autosomal dominant (AD) kindreds
(HUGO database, www.genenames.org).
The SPG3A form of ADHSP typically presents with a
pure phenotype, early onset and benign prognosis. The
SPG3A gene is mutated in approximately 10% of ADHSP
families, and it is considered the most common cause of
early-onset ADHSP [1].
We report peculiar phenotypic features of two patients
from an Italian family carrying a novel SPG3A mutation.
Written informed consent was obtained for both patients.
Patients and methods
Case 1
A 39-year-old woman had experienced progressive walk-
ing disturbance since 5 years of age. Her neurological
examination showed spastic gait, lower limb spasticity and
proximal weakness, four-limb hyperreflexia, positive jaw
jerk reflex, bilateral Troemner, ankle clonus and Babinski
signs. Slight bilateral dysmetric finger-to-nose testing and
dysdiadochokinesia were also present. There were no
sphincter or cognitive disturbances. The neurophysiologic
study showed normal motor and sensitive nerve conduction
velocities (M- and S-NCV), normal brainstem auditory and
visual evoked potentials; absent somatosensory and motor
evoked potentials (SSEP and MEP) from the lower limbs.
Brain MRI revealed mild vermis atrophy and wide frontal
subarachnoid spaces (Fig. 1a). Cerebral [18F]-fluorodeox-
iglucose PET showed hypometabolism in the cerebellum
and the dorsolateral frontal cortex (Fig. 1b).
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Case 2
The 70-year-old father of the patient described in Case 1
had 3-year progressive weakness of the right leg, leading to
the need of a cane. His neurological examination, at the age
of 68 years, revealed weakness, wasting, and sporadic
fasciculations in the lower limbs, particularly on the right
side where he had foot drop. Tendon reflexes were brisk
with left side prevalence and left ankle clonus, while right
ankle reflex was absent; the plantar responses were flexor.
Mental status, cranial nerves, sensory system, coordination,
muscle tonus, and upper limb strength were normal. The
neurophysiologic evaluation showed a severe decrease of
right external popliteal sciatic nerve muscle action poten-
tial amplitude on MNCV; chronic denervation on EMG of
different muscles (right biceps brachii, right and left first
dorsal interosseous, left vastus medialis, right and left
anterior tibialis, right internal gastrocnemius), signs of
active denervation at the lower limbs, normal genioglossus
EMG; prolonged central conduction time on SSEP and
normal MEP. Brain MRI was unremarkable; spine MRI
showed several disc protrusions, more evident at L4-S1
levels. At that time he received the diagnosis of clinically
probable-laboratory supported amyotrophic lateral sclero-
sis (ALS).
Recently he developed progressive dyspnea with the
need for a respiratory assistive device and severe impair-
ment of fine hand movements. A recent EMG confirmed
signs of active denervation even in the upper limbs (right
and left first dorsal interosseous, left deltoid).
Molecular analyses
Sequencing the SPG3A gene coding exons and flanking
intronic regions disclosed a novel heterozygous missense
mutation in exon 12 at nucleotide c.1247 G[A
(p.Arg416His) (Fig. 2a). Arginine 416 is highly conserved
among species (Fig. 2b) and Polyphen modelling analysis
(http://genetics.bwh.harvard.edu/pph/) predicts the amino
acid substitution to be possibly damaging, with a position-
specific independent counts (PSIC) score difference of
1.756.
The mutation was found also in case 2 but not in 25
ADHSP patients, in 50 sporadic cases nor in 250 Italian
healthy controls. Multiplex ligation-dependent probe
amplification [probe mixtures P165-HSP-B1 and P211-B2
HSP [MRC-Holland, The Netherlands)] [2], denaturing
high performance liquid chromatography and direct
sequencing of SPG4 [3] in case 1 did not detect any
pathogenic changes. Also, mutations in NIPA1/SPG6,
KIF5A/SPG10, REEP1/SPG31, and BSCL2/SPG17 had
been ruled out [4]. We have also excluded Krabbe disease
in the proband by b-galactocerebrosidase activity estima-
tion (5.4 nmol/h/mgP; normal value 2.0–6.0). The two
siblings of the proband refused both clinical and molecular
assessment.
Fig. 1 Axial and sagittal slices of MRI T1 weighted images (a) and
[18F] FDG PET scans (b) in case 1. Images were normalised in the
Montreal Neurological Institute space using SPM2 (Wellcome
Department of Imaging Neuroscience, London, UK). MRI shows
enlargement of the IV ventricle and mild cerebellar vermis atrophy.
The [18F] FDG cerebral distribution appears reduced in the cerebel-
lum, mainly in the vermis. Slight hypometabolism is evident in the
prefrontal cortex. L left side; R right side
J Neurol (2010) 257:328–331 329
123
A homology model of region encompassing residues
67–436 in atlastin-1 was also built up using the MOE
(molecular operating environment 2006, www.chemcomp.
com) software package (Fig. 2c).
Discussion
We detected a novel mutation (c.1247 G[A) in exon 12 of
the SPG3A gene in an Italian patient with HSP. This
mutation was also found in her father who presented with a
peculiar ALS-like phenotype. SPG3A encodes atlastin-1, a
dynamin/guanylate-binding protein with transmembrane
domains, likely involved in membrane trafficking and
axonal development [5]. Of the SPG3A mutations descri-
bed so far, about 35% are located in exon 12 [1]. The
mutation here detected causes an arginine to histidine
substitution in a conserved motif for protein kinase C
phosphorylation according to the Prosite search [6], in the
middle of an alpha helix near the C-terminus, just before
the transmembrane domain (Fig. 2c). It lies far from the
catalytic GTPase domain, suggesting a possible role in
membrane association or oligomerization.
To date there is convincing evidence that the ‘‘appar-
ently’’ pure phenotype of patients harboring mutations in
SPG4 might also be complicated by additional neurological
features, including cerebellar involvement and thin corpus
callosum [7] and dysarthria and ataxia with reduced
regional cerebellar blood flow at PET scan [8]. Case 1
showed clinical and neuroimaging features that suggest a
cerebellar involvement also in SPG3A, possibly related to
this novel mutation.
There are some reports of an ALS-like phenotype in
patients with mutations in SPG4. These include a case of
rapidly progressive spinal and bulbar upper motor neuron
syndrome [9] and that of a patient with early onset ALS
and long term survival [10]. Also, in a large screen of HSP
patients, neurophysiologic evidence of lower motor dys-
function was recorded in a subgroup of individuals har-
boring mutations in SPG4, one of whom showed
progressive bulbar dysfunction and respiratory insuffi-
ciency [11]. Even more recently, a new SPG4 mutation has
been associated with the clinical features of the Silver
syndrome (MIM #270685) which includes distal amyo-
trophies [12]. There are only two reports of axonal sensory-
motor neuropathy in SPG3A families [13, 14]. Case 2
showed clinical and neurophysiologic evidence of upper
and lower motor syndrome, fulfilling the El Escorial
diagnostic criteria for clinically probable-laboratory sup-
ported ALS (www.wfnals.org). The relationship between
the novel SPG3A mutation and ALS-like phenotype in this
patient remains unclear. It seems possible to hypothesize
either a double-trouble phenotype in a carrier of a mutation
in SPG3A or that an ALS-like phenotype is an additional,
A C 
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Fig. 2 a Electropherogram of the sequences flanking residue R416 in
the patient (upper panel) and a normal control (bottom panel). An
arrow indicates the p.Arg416His mutation. The sequence reported is
in the inverse direction. b Species alignments of 60 human atlastin
amino acids showing the conservation of residue R416 (boxed)
(GeneBank accession num.: NP 056999.2, XP 533252.2, NP
848743.1, NP 056999.2, XP 863862.1, NP 001072222). c Mutated
homology model of the V67-N436 sequence of human atlastin
isoform ‘‘a’’ was built up using the MOE package starting from the
crystal structures of human guanylate-binding protein 1 (hGBP1 PDB
1DG3 [15]). His416 is located in the helical domain
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though rare, clinical manifestation of the novel
p.Arg416His variant. Less likely, SPG3A mutations might
increase susceptibility for ALS.
Although further studies are required to clarify these
issues, it seems useful to alert neurologists to this possible
comorbid association and, more importantly, to call for a
complete neuroimaging assessment even in ‘‘pure’’
ADHSP patients.
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